Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma
Clinical trial NCT02304289 · TERMINATED
Trial details
- NCT number
- NCT02304289
- Sponsor
- University Hospital, Ghent
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-12-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.